# Your First Month on Wegovy Tablets: What to Realistically Expect
Starting any new prescription treatment raises natural questions. For oral Wegovy, there is an additional layer of novelty — this is a medicine that launched in the UK in June 2026, and clinical trial data only goes so far in preparing you for the practical day-to-day reality of taking it. This article draws on the available clinical evidence, the established experience base from injectable semaglutide users, and the known pharmacology of oral semaglutide to give you the most realistic picture of what your first four weeks is likely to involve.
It is not intended to replace your prescriber’s advice — which should always be your first port of call for questions about your specific health situation.
> Wegovy tablets are a prescription-only medicine. Always consult a qualified healthcare professional before starting or changing treatment.
—
## Week 1: settling in at 1.5mg
The starting dose for oral Wegovy is 1.5mg daily. This is the lowest dose in the escalation schedule, and it is intentionally low — designed to let your body adapt to GLP-1 receptor activation before higher doses are introduced.
For most people, week one feels relatively uneventful. Some people notice mild nausea, particularly around the time of day they take the tablet, or a slight dulling of appetite. Others feel almost nothing different. Both experiences are normal at 1.5mg.
The morning dosing routine takes some adjustment. Oral semaglutide must be taken in the morning on an empty stomach, with no more than 120ml of plain water. You then need to wait at least 30 minutes before eating or drinking anything else. For some people, this fits naturally into a morning routine — take the tablet when you wake up, shower and dress, then eat. For others, particularly early morning workers or parents managing school runs, it requires more deliberate planning.
Building the habit in week one matters more than any physiological effect. The dosing conditions are not optional — eating too soon reduces the amount of semaglutide your body absorbs, which reduces the medicine’s effectiveness.
—
## Weeks 2–3: potential side effects and appetite changes
By weeks two and three, if side effects are going to appear, they are most likely to do so around now. The most common side effects of oral semaglutide are gastrointestinal: nausea, constipation, diarrhoea, and occasional vomiting. These occur because GLP-1 receptors are present throughout the digestive system, and activating them slows gastric emptying — which is part of how the medicine reduces appetite, but can also cause temporary discomfort.
At the 1.5mg starting dose, these effects are typically mild to moderate and short-lived. Clinical trial data from the OASIS programme shows that most gastrointestinal side effects are concentrated in the first few weeks and tend to lessen as the body adjusts, even before any dose escalation occurs.
If nausea is a problem, some practical adjustments can help: eating smaller portions, choosing lower-fat foods, avoiding alcohol, and staying well hydrated. If side effects are severe or significantly affecting daily life, contact your prescriber — do not simply stop taking the medication without advice.
Appetite changes are also common from weeks two to three onwards. Most people notice some reduction in hunger — smaller appetite at mealtimes, feeling full sooner, or finding that foods previously craved now seem less appealing. This is the mechanism through which the medicine supports weight loss. It can feel unfamiliar at first.
—
## What weight loss to expect in month one
This is the question most people are keenest to answer, and the honest answer is: not much yet, and that is entirely normal.
At the 1.5mg starting dose, oral semaglutide is not operating at therapeutic weight-loss intensity. The dose will need to escalate to 4mg, then 9mg, then 25mg before you reach the doses studied in the OASIS 2 trial’s key efficacy endpoints. The starting dose is a tolerability phase.
Most people at 1.5mg experience modest, early weight loss in the range of 1–4kg over the first month. This is partly from the mild appetite reduction at starting dose and partly from the kinds of spontaneous dietary changes that many people make when they begin any treatment programme. It is not the result of semaglutide operating at full therapeutic effect.
Managing expectations here matters. People who expect dramatic weight loss in month one often feel discouraged by the modest early results. The clinical evidence is clear that results build over several months as doses escalate — the 15.1% average weight loss in OASIS 2 was measured at 68 weeks, not at 4 weeks.
—
## When to contact your prescriber
Most people complete month one without needing to contact their prescriber between check-ins. However, you should get in touch promptly if you experience:
– Persistent severe vomiting or inability to keep food or water down
– Symptoms of pancreatitis: severe, persistent abdominal pain radiating to the back (stop the medication and seek urgent medical attention)
– Signs of a serious allergic reaction: facial swelling, difficulty breathing, skin rash
– Symptoms suggesting low blood sugar (especially if you take other diabetes medications)
– Any side effect that is significantly affecting your daily functioning
Mild to moderate nausea that passes within a few days does not typically require prescriber contact, but your provider will usually schedule a check-in around weeks 4–6 to review your first month and discuss progression to the 4mg dose.
—
## Looking ahead: months 2–6
The first month is about establishing the habit and tolerability. Months two through six bring the dose escalations — 4mg at around month two, 9mg at month four, 25mg at month six — and progressively greater appetite suppression and weight loss effects.
Most people find the side effect profile repeats briefly with each dose increase: mild nausea for a week or two, then settling. By the 25mg maintenance dose, most of the tolerability adjustment is complete and the focus shifts to sustaining the lifestyle changes that the medication supports.
—
## Compare pre-order prices before you start
If you have not yet placed a pre-order, our comparison table lets you see all seven UK providers side by side — including true first-month cost after any fees and delivery charges.
[Compare Wegovy tablet prices →](/providers/)
—
*This article is for informational purposes only and does not constitute medical advice. Wegovy tablets are a prescription-only medicine. Individual experiences vary. Always consult a registered healthcare professional before starting or changing treatment. CompareWegovyPrices.co.uk is not affiliated with Novo Nordisk.*
